Name: SGP Balance Sheet - Spyglass Pharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SGP - Spyglass Pharma, Inc.

USD | NASDAQ | Healthcare

SGP Balance Sheet - Spyglass Pharma Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q1 FY 25	Q4 FY 24	Q4 FY 23
Cash And Short Term Investments
Cash And Equivalents	238.9	96.4	-	-	-
Restricted Cash	-	-	-	-	-
Short Term Investments	-	-	-	-	-
Cash And Short Term Investments	238.9	96.4	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-
Prepaid Expenses	1.7	0.9	-	-	-
Other Current Assets	-	-
Non-Current Assets
Property, Plant & Equipment Gross	4.2	3.5	-	-	-
Accumulated Depreciation	1.4	1.1	-	-	-
Property,Plant & Equipment Net	2.7
Current Liabilities
Accounts Payable	3.5	2.7	-	-	-
Short Term Debt	-	-	-	-	-
Deferred Revenue Current	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-
Operating Lease Liabilities Non-Current	1.6	1.6	-	-	-
Deferred Revenue Non-Current	-
Common Equity
Common Stock	0.0	0.0	-	-	-
Additional Paid In Capital	368.7	5.9	-	-	-
Retained Earnings	(118.5)	(104.7)
Supplementary Data
Total Debt	-	-	-	-	-
Net debt	-	-	-	-	-
Working Capital	246.7	100.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023
Cash And Short Term Investments
Cash And Equivalents	96.4	16.3	-
Restricted Cash	-	-	-
Short Term Investments	-	-	-
Cash And Short Term Investments	96.4	16.3	-
Receivables
Accounts Receivable	-	-	-
Current Assets
Inventory	-	-	-
Prepaid Expenses	0.9	0.7	-
Other Current Assets	-	-	-
Assets Held For Sale	-
Non-Current Assets
Property, Plant & Equipment Gross	3.5	2.7	-
Accumulated Depreciation	1.1	0.5	-
Property,Plant & Equipment Net	2.3	2.2	-
Long Term Investments
Current Liabilities
Accounts Payable	2.7	2.0	-
Short Term Debt	-	-	-
Deferred Revenue Current	-	-	-
Operating Lease Liabilities Current
Non-Current Liabilities
Long Term Debt	-	-	-
Operating Lease Liabilities Non-Current	1.6	3.5	-
Deferred Revenue Non-Current	-	-	-
Deferred Tax Liabilities
Common Equity
Common Stock	0.0	0.0	-
Additional Paid In Capital	5.9	4.4	-
Retained Earnings	(104.7)	(64.9)	-
Accumulated Other Comprehensive Income
Supplementary Data
Total Debt	-	-	-
Net debt	-	-	-
Working Capital	100.2	9.6	-
Book Value	(98.8)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)